Effect of postconditioning on myocardial 99mTc-annexin-V uptake: Comparison with ischemic preconditioning and caspase inhibitor treatment

Journal of Nuclear Medicine

Volumn 48, Issue 8, 2007, Pages 1301-1307

  Taki, Junichi ^a   Higuchi, Takahiro ^a   Kawashima, Atsuhiro ^b   Fukuoka, Makoto ^a   Kayano, Daiki ^a   Tait, Jonathan F ^c   Matsunari, Ichiro ^d   Nakajima, Kenichi ^a   Kinuya, Seigo ^a   Strauss, H William ^e  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Medical and Pharmacological Research Center Foundation   (Japan)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

99mTc annexin V; Apoptosis imaging; Caspase inhibitor; Ischemic preconditioning; Postconditioning

Indexed keywords

ANNEXIN V TC 99M; CASPASE INHIBITOR; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; QUINOLYLVALYL O METHYLASPARTYL (2,6 DIFLUOROPHENOXY) METHYL KETONE; TECHNETIUM 99M; THALLIUM 201; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; CELL DAMAGE; CELL DEGENERATION; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; IMAGE ANALYSIS; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; RAT; REPERFUSION; THORACOTOMY;

ANIMALS; ANNEXIN A5; APOPTOSIS; CASPASES; CYSTEINE PROTEINASE INHIBITORS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS;

EID: 34547772626     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.037408     Document Type: Article

References (23)

1. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA. 1998;95:6349-6354.
2. 99mTc annexin V. J Nucl Med. 1999;40:184-191.
3. Blankenberg FG, Tait JF, Strauss HW. Apoptotic cell death: its implications for imaging in the next millennium. Eur J Nucl Med. 2000;27:359-367.
4. Strauss HW, Narula J, Blankenberg FG. Radioimaging to identify myocardial cell death and probably injury. Lancet. 2000;356:180-181.
5. 94mTc. Bioconjug Chem. 2000;11:918-925.
6. Flotats A, Carrio I. Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imaging. 2003;30:615-630.
7. Boersma HH, Kietselaer BL, Stolk LM, et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med. 2005;46:2035-2050.
8. Maulik N, Kagan VE, Tyurin VA, Das DK. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol. 1998;274:H242-H248.
9. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-1556.
10. Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res. 2002;55:438-455.
11. 99mTc-labeled annexin V. J Nucl Med. 2004;45:1536-1541.
12. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-H588.
13. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res. 2006;70:200-211.
14. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis. 2003;8:345-352.
15. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230-232.
16. Kin H, Zhao ZQ, Sun HY, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004;62:74-85.
17. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol. 2004;44:1103-1110.
18. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation. 2005;112:2143-2148.
19. Tsang A, Hausenloy DJ, Yellon DM. Myocardial postconditioning: reperfusion injury revisited. Am J Physiol Heart Circ Physiol. 2005;289:H2-H7.
20. Wang HC, Zhang HF, Guo WY, et al. Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation. Apoptosis. 2006;11:1453-1460.
21. Sun HY, Wang NP, Halkos M, et al. Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis. 2006;11:1583-1593.
22. Dumont EA, Hofstra L, van Heerde WL, et al. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation. 2000;102:1564-1568.
23. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.